4-5628743-TAA-TAAAA
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1
The NM_147127.5(EVC2):c.1711-11_1711-10dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.091 ( 1107 hom., cov: 0)
Exomes 𝑓: 0.040 ( 318 hom. )
Consequence
EVC2
NM_147127.5 intron
NM_147127.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.151
Publications
4 publications found
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
- acrofacial dysostosis, Weyers typeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Ellis-van Creveld syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 4-5628743-T-TAA is Benign according to our data. Variant chr4-5628743-T-TAA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 349081.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EVC2 | ENST00000344408.10 | c.1711-11_1711-10dupTT | intron_variant | Intron 11 of 21 | 1 | NM_147127.5 | ENSP00000342144.5 | |||
| EVC2 | ENST00000310917.6 | c.1471-11_1471-10dupTT | intron_variant | Intron 11 of 21 | 1 | ENSP00000311683.2 | ||||
| EVC2 | ENST00000475313.5 | n.1471-11_1471-10dupTT | intron_variant | Intron 11 of 22 | 1 | ENSP00000431981.1 | ||||
| EVC2 | ENST00000509670.1 | n.*104-11_*104-10dupTT | intron_variant | Intron 12 of 22 | 1 | ENSP00000423876.1 |
Frequencies
GnomAD3 genomes AF: 0.0912 AC: 13554AN: 148592Hom.: 1101 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
13554
AN:
148592
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0507 AC: 9529AN: 187796 AF XY: 0.0473 show subpopulations
GnomAD2 exomes
AF:
AC:
9529
AN:
187796
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0404 AC: 51202AN: 1268394Hom.: 318 Cov.: 0 AF XY: 0.0393 AC XY: 24823AN XY: 631496 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
51202
AN:
1268394
Hom.:
Cov.:
0
AF XY:
AC XY:
24823
AN XY:
631496
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
6242
AN:
31480
American (AMR)
AF:
AC:
1303
AN:
39830
Ashkenazi Jewish (ASJ)
AF:
AC:
565
AN:
22372
East Asian (EAS)
AF:
AC:
3
AN:
35880
South Asian (SAS)
AF:
AC:
558
AN:
74562
European-Finnish (FIN)
AF:
AC:
3003
AN:
45904
Middle Eastern (MID)
AF:
AC:
325
AN:
5042
European-Non Finnish (NFE)
AF:
AC:
36873
AN:
960798
Other (OTH)
AF:
AC:
2330
AN:
52526
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.388
Heterozygous variant carriers
0
2130
4260
6390
8520
10650
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1374
2748
4122
5496
6870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0913 AC: 13577AN: 148700Hom.: 1107 Cov.: 0 AF XY: 0.0919 AC XY: 6659AN XY: 72466 show subpopulations
GnomAD4 genome
AF:
AC:
13577
AN:
148700
Hom.:
Cov.:
0
AF XY:
AC XY:
6659
AN XY:
72466
show subpopulations
African (AFR)
AF:
AC:
8939
AN:
40908
American (AMR)
AF:
AC:
780
AN:
14986
Ashkenazi Jewish (ASJ)
AF:
AC:
72
AN:
3412
East Asian (EAS)
AF:
AC:
1
AN:
5096
South Asian (SAS)
AF:
AC:
42
AN:
4654
European-Finnish (FIN)
AF:
AC:
765
AN:
9698
Middle Eastern (MID)
AF:
AC:
22
AN:
292
European-Non Finnish (NFE)
AF:
AC:
2758
AN:
66716
Other (OTH)
AF:
AC:
142
AN:
2048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
539
1079
1618
2158
2697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Aug 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 28, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 02, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Ellis-van Creveld syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.